Genentech's Levinson tapped as new Apple chairman

Art Levinson, the research scientist who led Genentech through a series of some of the most exciting breakthroughs in biotech, has been named non-executive chairman of Apple following the death of Steve Jobs. For Levinson, the new job comes as a reward for his decision to stick with the tech company and its wunderkind CEO when he was forced to choose between board positions at Apple and Google. "Apple is always focused on out-innovating itself ... and that is something I am very proud to be a part of," Levinson said. Report

Suggested Articles

German researchers uncovered 28 antibodies that neutralize COVID-19 and are working with Boehringer Ingelheim to advance them into clinical testing.

Oragenics is ending a phase 2 study of its oral mucositis drug, yanking its IND application and switching its focus to a COVID-19 vaccine.

The vehicle, which Blackstone claims is the largest life sciences private fund, has committed close to $1 billion to companies including Alnylam.